rxstat › Shortages › Ethinyl Estradiol Desogestrel

Ethinyl Estradiol Desogestrel (Reclipsen, Mirvala) shortage status

No current shortage

Source: Health Canada shortage reports · Updated Oct 27, 2026

Also sold as: Reclipsen, Mirvala, Marvelon, Freya

Ethinyl Estradiol Desogestrel has no current shortage reported in Canada. It has been in shortage before; the history is below.

A combined birth control pill used to prevent pregnancy.

Products affected
0 / 10
Reports on file
33

Shortage history

2023 2024 2025 2026

Shortage history (red bands = periods in shortage).

Reports by product

The DIN is printed on your prescription label.

Resolved
APRI 28
0.03MG 0.15MG · TABLET · TEVA CANADA LIMITED
DIN 02317206 · ended Jul 31, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 28
0.1500MG 0.0300MG · TABLET · APOTEX INC
DIN 02410257 · ended Apr 16, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410249 · ended Apr 2, 2026 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.1500MG 0.0300MG · TABLET · APOTEX INC
DIN 02410249 · ended Aug 14, 2025 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.1500MG 0.0300MG · TABLET · APOTEX INC
DIN 02410249 · ended Jul 11, 2025 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 28
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410257 · ended Oct 17, 2024 · Disruption of the manufacture of the drug.
Resolved
APRI 28
0.03MG 0.15MG · TABLET · TEVA CANADA LIMITED
DIN 02317206 · ended Dec 1, 2022 · Disruption of the manufacture of the drug.
Resolved
APRI 21
0.03MG 0.15MG · TABLET · TEVA CANADA LIMITED
DIN 02317192 · ended Dec 1, 2022 · Disruption of the manufacture of the drug.
Resolved
MIRVALA 21
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410249 · ended Nov 4, 2022 · Delay in shipping of the drug.
Resolved
FREYA 28
0.15MG 0.03MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02396610 · ended Oct 26, 2022 · Quality Hold
Resolved
FREYA 21
0.03MG 0.15MG · TABLET · MYLAN PHARMACEUTICALS ULC
DIN 02396491 · ended Oct 24, 2022 · Quality Hold
Resolved
MIRVALA 28
0.0300MG 0.1500MG · TABLET · APOTEX INC
DIN 02410257 · ended Jan 14, 2022 · Disruption of the manufacture of the drug.

Showing 12 of 33 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Ethinyl Estradiol Desogestrel. Health Canada has 33 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Ethinyl Estradiol Desogestrel is classified under “HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE” (ATC G03AA).

Recent changes

Common questions

What is Ethinyl Estradiol Desogestrel used for?

A combined birth control pill used to prevent pregnancy.

When will Ethinyl Estradiol Desogestrel be back in stock in Canada?

Ethinyl Estradiol Desogestrel has no active shortage; supply is normal per Health Canada reports.

Why is Ethinyl Estradiol Desogestrel in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (hormonal contraceptives for systemic use)

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.